Aytu BioPharma, Inc.AYTUNASDAQ
Loading
Year-over-year net income growth rate
Percentile
P10
Near historical low
vs 2Y Ago
-6.6x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -638.63% |
| Q3 2025 | 109.92% |
| Q2 2025 | -596.19% |
| Q1 2025 | 406.85% |
| Q4 2024 | -46.54% |
| Q3 2024 | 131.93% |
| Q2 2024 | -59.92% |
| Q1 2024 | -1212.27% |
| Q4 2023 | 97.29% |
| Q3 2023 | -230.48% |
| Q2 2023 | 65.88% |
| Q1 2023 | -7.58% |
| Q4 2022 | -854.78% |
| Q3 2022 | 95.64% |
| Q2 2022 | 69.81% |
| Q1 2022 | -361.47% |
| Q4 2021 | 58.54% |
| Q3 2021 | -46.60% |
| Q2 2021 | 25.38% |
| Q1 2021 | -167.30% |
| Q4 2020 | -121.20% |
| Q3 2020 | -36.90% |
| Q2 2020 | 41.01% |
| Q1 2020 | -2388.86% |
| Q4 2019 | 95.65% |
| Q3 2019 | 66.08% |
| Q2 2019 | -223.23% |
| Q1 2019 | 3.47% |
| Q4 2018 | -35.14% |
| Q3 2018 | -729.42% |
| Q2 2018 | 119.43% |
| Q1 2018 | 23.28% |
| Q4 2017 | 13.48% |
| Q3 2017 | -39.64% |
| Q2 2017 | 41.72% |
| Q1 2017 | -8.29% |
| Q4 2016 | 15.85% |
| Q3 2016 | 62.58% |
| Q2 2016 | -110.30% |
| Q1 2016 | -118.28% |